Am J Transplant, Volume 22, Suppl 3 Archives - Page 27 of 190 - ATC Abstracts

2022 American Transplant Congress
Low-Dose Aspirin is Effective in Preventing Transplant Renal Artery Stenosis: A Prospective Randomized Controlled Trial
X. Tian, W. Duan, X. Niu, X. Wu, C. Zhang, J. Zhao, Z. Wang, G. Cao, B. Ji, Y. Gu, H. Cao, T. Qin, F. Shao, T. Yan
Henan Provincial People's Hospital, Zhengzhou, Henan Province, China
*Purpose: Transplant renal artery stenosis (TRAS), the most common post-transplant vascular complication, leads to resistant hypertension, renal impairment, and even graft loss. No effective prophylactic…
2022 American Transplant Congress
Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Multicenter Analysis
M. L. Holzner¹, V. Mazzaferro², M. Droz dit Busset², L. Aldrighetti³, F. Ratti³, K. Hasegawa⁴, J. Arita⁴, G. Sapisochin⁵, P. Abreu⁵, W. Schoening⁶, N. Nevermann⁶, M. Schmelzle⁶, J. Pratschke⁶, S. Florman¹, K. Halazun⁷, M. E. Schwartz¹, P. Tabrizian¹
¹Recanati/Miller Transplantation Institute, Mount Sinai, New York, NY, ²University of Milan, Milan, Italy, ³San Raffaele Hospital, Milan, Italy, ⁴University of Tokyo, Tokyo, Japan, ⁵University of Toronto, Toronto, ON, Canada, ⁶Charite University, Berlin, Germany, ⁷Weill Cornell Medical Center, New York, NY
*Purpose: Recurrence of intrahepatic cholangiocarcinoma (ICC) after liver resection (LR) remains high and optimal therapy for recurrent ICC is challenging. Herein we assess the outcomes…
2022 American Transplant Congress
CMV Specific T Cell Immune Response in Hepatitis C Negative Kidney Transplant Recipients Receiving Transplant from Hepatitis C Viremic Donors and Hepatitis C Negative Donors
M. Z. Molnar¹, M. Tsujita², M. Talwar², V. Balaraman², A. Bhalla², J. D. Eason², S. S. Nouer², K. Sumida², A. Remport³, I. E. Hall¹, R. Griffin², G. George Rofaiel⁴, A. Azhar⁵
¹Department of Internal Medicine, Division of Nephrology & Hypertension, University of Utah, Salt Lake City, UT, ²University of Tennessee Health Science Center, Memphis, TN, ³Semmelweis University, Budapest, Hungary, ⁴Department of Surgery, Division of Transplantation and Advanced Hepatobiliary Surgery, University of Utah, Salt Lake City, UT, ⁵Division of Nephrology, Department of Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA
*Purpose: Kidney transplants (KT) from hepatitis C (HCV) viremic donors to HCV negative recipients has shown promising short-term and long-term outcomes. However, high incidence of…
2022 American Transplant Congress
The Other Reasons for Waitlist Removal
C. Martinez, J. Foutz, A. Placona, L. Cartwright
United Network for Organ Sharing, Richmond, VA
*Purpose: When a transplant program removes a candidate from the waitlist, they must either select a pre-defined removal code or type a response into the…
2022 American Transplant Congress
HLA DSA May Not Be Detected in Many Solid Organ Recipients
J. C. Quon¹, R. M. Lestz², J. Menteer², N. Fotiadis², L. A. Baxter-Lowe²
¹Keck School of Medicine, Los Angeles, CA, ²Children's Hospital Los Angeles, Los Angeles, CA
*Purpose: Clinically significant HLA antibodies may not be detected if their unique HLA epitopes are not represented in the single antigen reagents that are routinely…
2022 American Transplant Congress
Renal Transplants In Hepatitis C Negative Recipients With Nucleic Acid Positive Donors Using Two Weeks Of DAA Prophylaxis (Rehanna – 2)
N. M. Desai¹, S. Leung¹, J. Motter¹, F. Naqvi², N. Bair¹, B. Barnaba², D. Warren¹, D. Segev¹, C. Durand²
¹Surgery, Johns Hopkins University, Baltimore, MD, ²Medicine, Johns Hopkins University, Baltimore, MD
*Purpose: To mitigate the organ shortage and underutilization of hepatitis C-infected deceased donor (HCV D+) organs, we evaluated the use of HCV D+ kidneys in…
2022 American Transplant Congress
Abnormal B Cell Profile Associated with Inadequate Antibody Response to MRNA SARS-COV-2 Vaccine Can Be Overcome with a Third Vaccine Dose in Adolescent Kidney Transplant Recipients
C. Crane, E. Phebus, L. Loop, C. Anterasian, B. Geng, E. Ingulli
Pediatrics, UCSD Rady Children's, San Diego, CA
*Purpose: mRNA SARS-CoV-2 vaccines are highly efficacious in the general population but have shown a diminished response in immunosuppressed adolescent kidney allograft recipients. We investigated…
2022 American Transplant Congress
Patient-Reported Physical Function Correlates with Liver Frailty Index and 4-Meter Gait Speed in Patients with Cirrhosis
A. J. Thuluvath, J. Peipert, K. Belfanti, S. Morrissey, O. Siddiqui, J. Levitsky, Z. Dietch, A. Flores, D. P. Ladner
Northwestern University Feinberg School of Medicine, Chicago, IL
*Purpose: Frailty is highly prevalent in patients with end-stage liver disease and strongly predicts waitlist and post-transplant mortality. The Liver Frailty Index (LFI) and 4-meter…
2022 American Transplant Congress
The Gut Microbiome in the Critical Care Setting Post-Heart Transplantation
M. Dela Cruz¹, H. Lin², E. Adler², M. Khalid², J. Boissiere², G. Kim¹, S. Pinney¹, E. Pamer², A. Nguyen¹
¹Section of Cardiology, University of Chicago, Chicago, IL, ²Duchossois Family Institute, University of Chicago, Chicago, IL
*Purpose: Given its potential impact on immune activation and systemic inflammation, we aim to investigate gut microbiome compositions and metabolites during critical illness in the…
2022 American Transplant Congress
Utilization and Discard of Organs from Covid -19 Infected Donors: A Us National Registry Analysis
A. Azhar¹, I. Moinuddin¹, A. B. Gungor², M. K. Morales¹, M. Z. Molnar³, B. Tanriover², G. Gupta¹
¹Virginia Commonwealth University, Richmond, VA, ²University of Arizona, Tuscon, AZ, ³University of Utah, Salt Lake City, UT
*Purpose: Expansion of the donor pool remains a major unmet need for solid organ transplants (SOT). Early data suggests that at least some severe acute…